Testing the Engaged Approach to Lung Cancer Screening

N/AActive Not RecruitingNCT06327074

University of Colorado, Denver40 enrolled

Overview

The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

Lung Cancer

Interventions

Engaged Approach to Lung Cancer ScreeningBEHAVIORAL

Sites randomized to use the EA-LCS materials will be given password-protected access to the program/toolkit web portal and encouraged to use any materials that fit the normal flow of clinic procedures. Materials available include both staff-facing and LCS candidate-facing materials. Staff-facing materials include: * Program website/manual/toolkit overview * Implementation insights with experts video series * Clinical placement placards * Program and clinician communication tools Candidate-facing materials include: * Program welcome letter * Maps and directions template * Communication preferences * Candidate letter templates (N=\~8) * Program newsletter template and instructions * Lung nodule size comparison chart

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: The trial incorporates a multilevel assessment and enrollment involves inclusion criteria at two levels: (1) LCS Program and (2) LCS Program Staff member. Program inclusion criteria (n = up to 8 sites): * Must conduct at least 50 low-dose computed tomography (LDCT) scans per year (baseline + follow-up) * Must be able to identify a primary contact person for LCS program operations (e.g., program coordinator, program navigator, program manager, etc.) Staff member inclusion criteria (n \~ 5 at each site/\~40 participants total): * Identified staff member of the LCS program site * \>18 years of age * Must be able to complete study surveys and interviews in English * Willing to provide informed consent Exclusion Criteria: * none

Locations (1)

University of Colorado Hospital

Denver, Colorado, United States

Outcomes

Primary Outcomes

Percentage of the intervention group who would like to continue the EA-LCS framework

Time frame: 7 months

Percentage of the intervention group who would recommend the EA-LCS framework to other programs

Time frame: 7 months

Percentage of participants who would describe the framework as workable

Time frame: 7 months

Secondary Outcomes

Evaluate the intervention acceptability by Acceptability of Intervention Measure (AIM)

Indexes of intervention acceptability will be measured by the Acceptability of Intervention Measure (AIM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.

Time frame: 12 months

Evaluate the intervention appropriateness by Intervention Appropriateness Measure (IAM)

Indexes of intervention appropriateness will be measured by the Intervention Appropriateness Measure (IAM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.

Time frame: 12 months

Evaluate the intervention feasibility by Feasibility of Intervention Measure (FIM)

Indexes of intervention feasibility will be measured by the Feasibility of Intervention Measure (FIM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.